宫颈癌治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00004058
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

【研究报告】宫颈癌治疗市场预计将从2022年的94.3394亿美元增长到2030年的140.7408亿美元;预计 2022 年至 2030 年市场复合年增长率为 5.13%。

市场洞察和分析师观点:

宫颈癌治疗市场预测可以帮助利益相关者规划其增长战略。< br>
宫颈癌是指发生在子宫颈细胞(即连接阴道的子宫下部)的癌症。 90%的宫颈恶性肿瘤是由于HPV感染引起的,并通过涂片筛查确诊。宫颈癌患病率的增加和HPV感染的增加是推动宫颈癌治疗市场增长的关键因素。然而,对诊断和治疗方法缺乏认识阻碍了市场的增长。宫颈癌治疗市场趋势包括宫颈癌诊断和药物研发的增加。

增长动力和挑战:

宫颈癌患病率的增加推动宫颈癌治疗市场

在全球范围内,癌症正在成为导致死亡的主要原因之一。根据世界卫生组织 (WHO) 的数据,2019 年,癌症是 183 个国家 70 岁以下人群的首要死因,而在其他 123 个国家中,癌症是全球第四大常见死因。根据世界卫生组织2021年3月发布的数据,2020年有近1000万人死于各种癌症。正在考虑的市场已显示出显着扩张,这可能与全球女性宫颈癌发病率上升有关。据世界卫生组织 (WHO) 统计,宫颈癌每年夺去超过 270,000 名女性的生命。由于该疾病发现较晚,较贫穷国家的宫颈癌死亡率很高。

宫颈癌患病率的不断上升给世界各地的医疗保健系统带来了负担。根据国际癌症研究机构 (IARC) 的数据,到 2040 年,全球新增癌症病例负担预计将达到约 2750 万,该疾病可能导致约 1.63 亿人死亡。生活方式改变、吸烟、体力活动的减少以及不确定的健康和气候条件预计将在未来几年增加全世界的癌症负担。因此,控制和预防全球范围内不断增加的癌症数量至关重要。

人们、医疗保健提供者和政策制定者对宫颈癌缺乏认识;获得高质量医疗保健服务和宫颈筛查计划的机会有限;缺乏功能性转诊系统是导致宫颈癌高发病率和死亡率的因素之一。由于细胞学筛查和早期宫颈病变快速治疗的普及,工业化国家的宫颈癌发病率和死亡率有所下降。实施基于人群的宫颈筛查并提高低收入和中等收入国家 (LMIC) 的接受度对于降低宫颈癌死亡率至关重要。提高对风险因素的认识,例如年轻时第一次性交和有多位男性性伴侣;与 HPV 8、9 和 10 型相关的高风险;年轻时第一次足月怀孕;长期使用口服避孕药;艾滋病毒感染可能有助于提高筛查项目的参与度。更好地了解宫颈癌的症状,如经间期阴道出血、绝经后阴道出血、性交后阴道出血、阴道分泌物恶臭和下腹疼痛,可能有助于女性尽早寻求帮助。因此,人群对宫颈癌缺乏认识阻碍了宫颈癌治疗市场的增长。

战略见解

报告细分和范围:

细分分析:

根据类型,市场分为鳞状细胞癌、腺鳞癌和腺癌。鳞状细胞癌细分市场在 2022 年占据更大的宫颈癌治疗市场份额,预计 2022 年至 2030 年期间复合年增长率更高。根据产品,市场分为手术、放射治疗、化疗、免疫治疗和治疗性疫苗。预计到 2030 年,手术细分市场将占据重要份额。就最终用户而言,市场分为医院、家庭护理、癌症中心等。就最终用户而言,医院细分市场在 2022 年占据最大的宫颈癌治疗市场份额。

区域分析:

就地理而言,宫颈癌治疗市场报告的范围包括北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。 2022年,北美占据最大的宫颈癌治疗市场份额。在北美,美国占有重要份额。持续不断的研发活动、政府和其他公共和私人组织的财政援助、IT 与制药公司之间的合作伙伴关系以及神经系统疾病发病率的上升主要推动了该国的市场增长。此外,政府为改进测试程序而采取的战略举措预计将在预测期内使市场受益。越来越多地采用与罕见疾病有关的法规很可能会带来市场扩张的机会。例如,美国癌症协会(ACS)于2020年9月修订了宫颈癌筛查标准。

行业发展和未来机遇:

宫颈癌治疗市场分析是通过识别和评估市场上的主要参与者。主要市场参与者采取的一些举措如下:

2024 年 1 月,辉瑞公司 (Pfizer Inc.) 和 Genmab A/S 宣布美国食品和药物管理局 (FDA) 接受补充生物制剂许可申请(sBLA) 将 TIVDAK (tisotumab vedotin-tftv) 批准用于治疗在一线治疗期间或之后疾病进展的复发性或转移性宫颈癌患者。处方药使用者收费法案(PDUFA)目标日期为2024年5月9日,该申请已获得优先审评。 2023年9月,广州格洛丽亚生物科技(GloriaBio)宣布Zimberelimab注射液(宇拓,GLS-010)全人源抗PD-1单克隆抗体已获中国国家药品监督管理局(NMPA)批准上市。该注射液可作为单一疗法治疗复发性或转移性宫颈癌(R/M CC)患者。全球批准用于治疗宫颈癌的第三种免疫检查点抑制剂(ICI)抗体是zimberelimab,这是中国第一个也是唯一一个获得批准的抗体。竞争格局和主要公司:

F. Hoffmann-La Roche Ltd、Merck Sharp、Dohme Corp.、GlaxoSmithKline plc.、Genentech Inc.、Amgen Inc.、Advaxis Inc.、Biocon、Allergan Inc.、Pfizer Inc.和 AstraZeneca 是宫颈癌领域的几家主要公司。癌症治疗市场报告。这些公司专注于扩大产品范围,以满足全球不断增长的消费者需求。他们的全球影响力使他们能够为许多客户提供服务,从而扩大他们的市场份额。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is cervical cancer treatment ?

Cervical cancer refers to the cancer that occurs in the cells of the cervix, i.e., the lower part of the uterus that connects to the vagina. In 90% of the cases, cervical malignancies occur due to the HPV infection and are diagnosed through smear screening.

Who are the major players in the cervical cancer treatment market?

The cervical cancer treatment market has major market players, including F. Hoffmann-La Roche Ltd, Merck Sharp, Dohme Corp., GlaxoSmithKline plc., Genentech Inc., Amgen Inc., Advaxis Inc., Biocon, Allergan Inc., Pfizer Inc., and AstraZeneca.

What factors drive the cervical cancer treatment market?

The increasing prevalence of cervical cancer and the rise in HPV infections are the key factors driving the cervical cancer treatment market growth. However, the lack of awareness about the diagnosis and treatment methods hampers the growth of the market. Cervical cancer treatment market trends include the increasing R&D for cervical cancer diagnosis and drugs

What was the estimated cervical cancer treatment market size in 2022?

The cervical cancer treatment market was valued at US$ 9,433.94 million in 2022.

Which slice product segment dominates the cervical cancer treatment market?

Based on product, the market is divided into surgery radiation therapy, chemotherapy, immunotherapy, and therapeutic vaccines..

What are the growth estimates for the cervical cancer treatment market till 2030?

The cervical cancer treatment market is expected to be valued at US$ 14,074.08 million in 2030.

Which type segment dominates the cervical cancer treatment market?

Based on type, the cervical cancer treatment market is segmented into squamous cell carcinoma, adenosquamous carcinoma, and adenocarcinoma. The squamous cell carcinoma segment held a larger cervical cancer treatment market share in 2022 and is anticipated to register a higher CAGR during 2022–2030.

The List of Companies - Cervical Cancer Treatment Market

  1. F. Hoffmann-La Roche Ltd
  2. Merck Sharp
  3. Dohme Corp.
  4. GlaxoSmithKline plc.
  5. Genentech, Inc.
  6. Amgen Inc.
  7. Advaxis, Inc.
  8. Biocon
  9. Allergan, Inc
  10. Pfizer Inc
  11. AstraZeneca

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports